Doctors in Texas are testing two new eye drops to treat wet and dry age-related macular degeneration (AMD). Data from clinical trials will reveal whether the drops are effective within two years.
The wet AMD drops - called TG100801 - is designed to block new blood vessel growth and leakiness and reduce inflammation.
The dry AMD drops, known as Hydergine, is like an antioxidant or an "eye vitamin". The drops are used four times a day.
The drops are not available to the public yet. But doctors in the study say they're hopeful. Click here to read more and here to watch a video of a patient who is trying out the drops.
The wet AMD drops - called TG100801 - is designed to block new blood vessel growth and leakiness and reduce inflammation.
The dry AMD drops, known as Hydergine, is like an antioxidant or an "eye vitamin". The drops are used four times a day.
The drops are not available to the public yet. But doctors in the study say they're hopeful. Click here to read more and here to watch a video of a patient who is trying out the drops.